This is a preview of subscription content, log in via an institution to check access.
Reference
Chan GCK, et al. Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019 (COVID-19) Clinical Infectious Diseases : 2 Aug 2023. Available from: URL: http://doi.org/10.1093/cid/ciad371
Rights and permissions
About this article
Cite this article
Nirmatrelvir/ritonavir well tolerated for COVID-19 in patients with CKD. Reactions Weekly 1969, 12 (2023). https://doi.org/10.1007/s40278-023-44478-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-44478-8